Enzalutamide Extends Survival in High-Risk Prostate Cancer

Overall survival data from EMBARK trial support enzalutamide plus leuprolide as standard of care.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/enzalutamide-extends-survival-high-risk-prostate-cancer-2025a1000sk5?src=rss

Author :

Publish date : 2025-10-21 14:48:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Enzalutamide Extends Survival in High-Risk Prostate Cancer

Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema

Don’t Fear Oseltamivir in Kids Hospitalized With Flu

Related Posts

A simple hack to help you switch off after work

Ultraprocessed Foods Tied to Early Colorectal Adenoma Risk

Livers of MASLD Patients End Up Less Fatty With Novel Injectable

U.S. Bishops Officially Ban Gender-Affirming Care at Catholic Hospitals

This Drug Might Make Chronic Steroid Therapy Safe in Rheumatic Disease

Managing Hypothyroidism in Older Adults: A Nuanced Decision

A simple hack to help you switch off after work

Ultraprocessed Foods Tied to Early Colorectal Adenoma Risk

Livers of MASLD Patients End Up Less Fatty With Novel Injectable

U.S. Bishops Officially Ban Gender-Affirming Care at Catholic Hospitals

This Drug Might Make Chronic Steroid Therapy Safe in Rheumatic Disease

Managing Hypothyroidism in Older Adults: A Nuanced Decision

Physicians, Hospitals Grapple With Looming Medicaid Cuts

Ancient silver goblet preserves oldest known image of cosmic creation

Categories

Archives